Yan-jun Zhong

机构：Wuhan University, Zhongnan Hospital of Wuhan University, Hubei Cancer Hospital

发表论文 7 篇 · 总被引 257 次 · h-index 5

代表论文

• Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (2012 · International Journal of Oncology · 被引 151)
• Cathepsin B cleavable novel prodrug Ac‐Phe‐Lys‐PABC‐ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis (2011 · Cancer · 被引 52)
• Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study (2013 · Journal of Translational Medicine · 被引 31)
• Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity (2014 · Molecular Cancer · 被引 12)
• Anticancer effects of Ac-Phe-Lys-PABC-doxorubicin via mitochondria-centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC-803 cells (2013 · Oncology Reports · 被引 10)
• A novel prodrug of adriamycin in the treatment of gastric cancer peritoneal carcinomatosis (2012 · Zhonghua shiyan waike zazhi · 被引 1)